Assessing the impact of hormonal contraceptive use on menstrual health among women of reproductive age - a systematic review
This systematic review found that hormonal contraceptives are effective in treating menstrual bleeding issues and associated conditions like endometriosis, fibroids, and PMDD, improving quality of life.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (55)
- A comparison of two different oral contraceptives in patients with severe primary dysmenorrhoea via openalex
- A randomized, double-blind, placebo-controlled pilot study of the comparative effects of dienogest and the combined oral contraceptive pill in women with endometriosis via openalex
- Combined oral contraceptive therapy in women with posterior deep infiltrating endometriosis via openalex
- Comparing the Effect of Dienogest and OCPS on Pain and Quality of Life in Women with Endometriosis: A Randomized, Double-Blind, Placebo-Controlled Trial via openalex
- Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study via openalex
- Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial via openalex
- Efficacy and Safety of Estradiol Valerate/Dienogest for the Management of Heavy Menstrual Bleeding: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase III Clinical Trial via openalex
- Efficacy of Low-Dose Estrogen-Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis via openalex
- Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study via openalex
- Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial via openalex
- Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo-controlled, double-blind, randomized trial via openalex
- Evaluation of the efficacy, safety, and clinically recommended dose of dienogest in the treatment of primary dysmenorrhea: a randomized, double-blind, multicenter, placebo-controlled study via openalex
- Hormonal contraception in women with endometriosis: a systematic review via openalex
- Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex
- Mifepristone 2.5, 5, 10mg versus placebo in the treatment of endometriosis via openalex
- Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference? via openalex
- Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomized trial via openalex
- Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study via openalex
- Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision via openalex
- Potentized estrogen in homeopathic treatment of endometriosis-associated pelvic pain: A 24-week, randomized, double-blind, placebo-controlled study via openalex
- Ulipristal acetate use in adenomyosis: A randomized controlled trial via openalex
- Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up via openalex
- W2900812770 via openalex
- W2912672173 via openalex
- W2946788536 via openalex
- W2984199235 via openalex
- W3008521790 via openalex
- W3027188873 via openalex
- W3112490422 via openalex
- W3119761837 via openalex
- W3134049157 via openalex
- W4200449497 via openalex
- W4251291328 via openalex
- W2789792078 via openalex
- W1988116546 via openalex
- W1998495772 via openalex
- W2024426672 via openalex
- W2027837220 via openalex
- W2033358136 via openalex
- W2062694026 via openalex
- W2078370543 via openalex
- W2079008410 via openalex
- W2081605462 via openalex
- W2094252128 via openalex
- W2101535787 via openalex
- W2106587450 via openalex
- W2134535954 via openalex
- W2155493571 via openalex
- W2171904793 via openalex
- doi:10.1097/aog.0b013e3182118ac3 via openalex
- W2252484909 via openalex
- W2468286513 via openalex
- W2547304893 via openalex
- W1966764641 via openalex
- W2794573996 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-10-13T06:10:10.580696+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-13T06:08:01.426188+00:00